# OnCo record pf-08634404 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pf-08634404/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "pf-08634404" ;
  schema:name "PF-08634404"@en ;
  schema:description "PF-08634404 is an experimental investigational agent whose form is not stated in the registry from Pfizer in phase 3 trials for colorectal cancer, gastric & gastro-oesophageal junction cancer and oesophageal cancer, with its target not yet stated publicly."@en ;
  schema:url <https://onco.cc/drugs/pf-08634404/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=SSGJ-707> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "bispecific antibody (PD-1 x VEGF, per the sponsor's pipeline page; form not stated in the registry record)" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/ovarian/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/symbiotic-gi-03/>, <https://onco.cc/trials/symbiotic-gi-16/>, <https://onco.cc/trials/symbiotic-lung-04/>, <https://onco.cc/trials/symbiotic-lung-01/>, <https://onco.cc/trials/nct06980272/>, <https://onco.cc/trials/nct07227012/>, <https://onco.cc/trials/nct06522828/>, <https://onco.cc/trials/nct07476287/>, <https://onco.cc/trials/nct07227415/>, <https://onco.cc/trials/nct07227298/>, <https://onco.cc/trials/nct07489066/>, <https://onco.cc/trials/nct06493760/>, <https://onco.cc/trials/nct07421700/> .